US Edition
inTRAvent Medical Appoints Dr. Adam S. Arthur as Chief Clinical Strategy Officer
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
inTRAvent Medical Appoints Dr. Adam S. Arthur as Chief Clinical Strategy Officer
BLUE BELL, PA — inTRAvent Medical has announced the appointment of Dr. Adam S. Arthur, MD, MPH, as Chief Clinical Strategy Officer (CCSO). Dr. Arthur will play a pivotal role in shaping the company’s clinical strategy as it prepares for the launch of SOLOPASS®, its advanced platform for external ventricular drain (EVD) placement. He will also guide the development of minimally invasive applications aimed at improving neurocritical care practices…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
